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ABSTRACT The structural basis of the wide variability of the physical properties of fibrin clots and the process of
assembly of the clot were investigated by electron microscopy of fibers formed under various ionic conditions. In
addition, highly specific proteolytic enzymes from different snake venoms were used to remove selectively only the A
(batroxobin) or the B (venzyme) fibrinopeptides from fibrinogen, in contrast to thrombin, which removes both pairs.
Fibers produced by cleavage of only the B fibrinopeptides displayed a characteristic band pattern indistinguishable from
that of fibers formed upon removal of either the A fibrinopeptides alone or of both pairs. Computer modeling studies
suggest that there is a unique molecular packing that gives rise to this fibrin band pattern. These findings imply that the
release of either fibrinopeptide triggers similar modes of aggregation; the intermolecular binding sites can be localized
to particular molecular domains. The diameters of fibers formed with each condition of enzyme, pH, salt concentration,
and temperature were measured from electron micrographs. All fibers, except for those produced at both high ionic
strength and pH, had about the same average diameter of 85 ± 13 nm. The degree of lateral aggregation of the fibers
themselves varied greatly, however; fibers aggregated more readily with cleavage of both pairs of fibrinopeptides and at
lower pH and salt concentrations. The formation of such thick fiber bundles increases the stability of the clot and its
resistance to proteolytic dissolution.
INTRODUCTION
The fibrin blood clot plays a vital role in many biological
and pathological processes, including hemostasis, thrombo-
sis, infection, inflammation, wound healing, and tumor
growth. The physical properties of the clot, such as its
density, strength, stability, porosity, flexibility, etc., largely
determine its interactions with molecules, cells and fluid.
Therefore, knowledge of the structural determinants of
these properties is necessary for an understanding of the
involvement of fibrin in any of the physiological processes
just listed. Furthermore, information about molecular
events that control the different forms that a biological
structure can assume may be applicable to systems in other
areas of biophysics as well. Much of the past research on
the structure and assembly of fibrin has been focused- at the
molecular level.
Fibrinogen is the key structural protein in blood clotting.
It has a molecular weight of 340,000 and is made up of
three pairs of chains, (Aa, Bf3, Y)2, linked together by
disulfide bonds. The complete amino acid sequence of
fibrinogen and the pattern of disulfide linkages are now
known (for reviews of many aspects of fibrinogen and
fibrin, see Mosesson and Doolittle, 1983). A slightly
modified bovine fibrinogen has been crystallized, providing
the basis for a high resolution structure determination
(Tooney and Cohen, 1972, 1977; Cohen and Tooney, 1974;
Weisel et al., 1978). Analysis of a variety of crystalline
forms by electron microscopy, computer image processing,
and x-ray crystallography has yielded a low resolution
model for the shape of fibrinogen (Weisel et al., 1981,
1985a,b; Cohen et al., 1983). The molecule consists of a
central globular domain, the disulfide knot where the
amino termini of all six chains are linked together, proxi-
mal and distal end domains, which comprise the COOH-
termini of the d- and 'y-chains, respectively, and the a
domain, which comprises the COOH-termini of both a-
chains. The central and end regions are joined by three-
stranded a-helical coiled-coils that are interrupted by a
nonhelical segment in the middle. (A simplified represen-
tation of the molecule is included as part of Fig. 1.)
Upon cleavage of the A and B fibrinopeptides with
thrombin (to form [a, ,B, Y]2 sometimes called des-AABB
fibrin, fibrin II, or a#3 fibrin), there is a dramatic change in
solubility that causes the molecules to aggregate to form
fibrin fibers. These fibers have a repeat of 22.5 nm as
determined by x-ray diffraction or electron microscopy and
a characteristic band pattern as observed by electron
microscopy (for a review of fibrin structure, see Weisel et
al., 1983). Although the repeat was explained some time
ago as arising from 45.0-nm long molecules that are
half-staggered, the band pattern itself could not be
accounted for until more information about the molecular
structure has become available recently (Weisel et al.,
1981, 1983; Weisel, J. W., manuscript submitted for
publication).
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FIGURE 1 A model for fibrin assembly involving two sets of complementary binding sites: one for protofibril formation and another for
lateral aggregation of protofibrils. The mechanism depicted is similar to that proposed by Blomback et al. (1978). The molecular shape is that
determined by Weisel et al. (1985); but for clarity the a domain is not shown. The globular regions are: central domain (or NH2-terminal
disulfide knot), distal end domain (or y domain), proximal end domain (,B domain), and a small plasmin-sensitive domain that interrupts the
rod-like, three chain, a-helical coiled-coil. The A fibrinopeptides are shown as black semicircles while the B peptides are black triangles. When
the fibrinopeptides are removed, binding sites are exposed: A sites are semicircular holes, while the B sites are triangular holes. The sites
complementary to those just described are the knobs that are always present on the distal end domains: a sites are semicircular knobs while the
b sites are triangular knobs. This scheme depicts the removal of the A fibrinopeptides to form half-staggered dimers and then a two-stranded
protofibril, both through the interaction of the A:a complementary binding sites. After cleavage of the B fibrinopeptides, the B:b
complementary binding sites interact to allow lateral aggregation of protofibrils. The important point here is that each set of sites, A:a or B:b,
on one molecule is interacting with the complementary sites on a different molecule.
At a higher level of organization, it has been known for
some time that the physical properties of clots vary consid-
erably depending upon the conditions under which they are
made (Ferry and Morrison, 1947). Extensive characteriza-
tion (primarily by light-scattering methods) of these dif-
ferent forms of clots and fibrin films has been carried out
by Ferry and coworkers and many others (a few examples
of recent work are Burchard and Muller, 1980, 1982; Carr
et al., 1977; Carr and Hermans, 1978; Cavazza et al.,
1981; Hantgan and Hermans, 1979; Hantgan et al., 1980;
Muller et al., 1981); recently, some electron microscopic
observations of fibrin clots and films in cross-section and in
deformed states has been reported (Muller et al., 1984).
Probably the most fundamental distinction is between
coarse and fine clots. Coarse clots are opaque and are
ordinarily formed at low pH and low salt concentration,
whereas fine clots are translucent and are produced at
higher pH and salt concentration.
Binding sites involved in the formation of the fibrin clot
have been identified and one pair has been partially
localized in the amino acid sequence. Sites exposed by
removal of the A fibrinopeptides in the central domain
(called "A" sites) bind to complementary sites (called "a"
sites) that are always present in the distal end domain, or y
domain (see the top part of Fig. 1). A peptide consisting of
residues 374-396 of the 'y-chain binds to the central
domain (Olexa and Budzynski, 1981; Horwitz et al.,
1984); these and other experiments indicate that this
peptide constitutes at least part of the "a" site. Further-
more, another peptide consisting of the residues at the
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amino terminus of the a-chain of fibrin (i.e., part of the
"A" site exposed by removal of the A fibrinopeptide),
Gly-Pro-Arg-X, inhibits the assembly of fibrin monomers
to form fibers (Laudano and Doolittle, 1978, 1981; Doolit-
tle and Laudano, 1980; Laudano et al., 1983). This peptide
also binds to the D fragment of fibrinogen, which is the end
region of the molecule. The important concept that has
been supported by the experimental data is that aggrega-
tion occurs when the A fibrinopeptides are cleaved, expos-
ing the "A" binding sites (in the central domain) that
interact with the "a" sites (in the y domain), which are
always available (Blomback et al., 1978). Although the
identified peptides undoubtedly represent only part of
complex three-dimensional sites, this scheme of comple-
mentary binding sites does account for the half-staggered
assembly of molecules in fibrin. The early aggregates in the
formation of the clot, termed two-stranded protofibrils,
have been observed by electron microscopy in the early
stages of clotting (Fowler et al., 1981; Erickson and
Fowler, 1983; Williams, 1983; Krakow et al., 1972). The
two-stranded protofibril is the expected result of assembly
mediated by sets of complementary binding sites (Fig. 1).
More detailed structural information about the two-
stranded protofibril has also been obtained by computer
image analysis of a microcrystalline form of modified
fibrinogen in which the molecular packing is similar to that
of fibrin (Weisel et al., 1983). The results of this analysis,
consistent with the biochemical data, show that the mole-
cules making up the protofibril face each other so that the
protofibril is a closed structure.
The role of the release of the B fibrinopeptides in the
formation of the clot has been controversial. Blomback
first postulated that the A fibrinopeptides are responsible
for linear aggregation while the B fibrinopeptides are
involved in lateral aggregation (Laurent and Blomback,
1958). This proposal was based on differences in turbidity
(in solvent conditions that prevented the formation of
fibers) between fibrin with both fibrinopeptides or only the
A peptides removed. This idea was later refined by taking
into account more data on the chemistry and kinetics of
assembly (Blomback et al., 1978). It was proposed that
there were binding sites (called "b" sites) that were
complementary to those exposed by removal of the B
fibrinopeptides (called "B" sites). In other words, this is a
scheme like that described above for the A fibrinopeptides,
but it was suggested that the B:b sites are involved in
aggregation of protofibrils with each other. One version of
this proposal is outlined in Fig. 1, modified slightly from
the original formulation and using the low resolution shape
determined for fibrinogen.
Insight into the precise roles of the fibrinopeptides has
been gained by the use of proteolytic enzymes that specifi-
cally cleave only the A or B fibrinopeptides. Enzymes such
as batroxobin from Bothrops atrox remove only the A
peptides; batroxobin thus produces the species (a, Bf3, Y)2,
sometimes called des-AA fibrin, fibrin I, or a-fibrin. A
venom from the copperhead snake, Ancistrodon contor-
trix, contains an enzyme, commonly called venzyme, that
preferentially removes the B fibrinopeptides (Shainoff
and Dardik, 1983); venzyme thus produces the species
(Aa, , 'Y)2, also called des-BB fibrin or fA-fibrin. Thrombin
removes both pairs, but the B peptides are cleaved more
slowly-primarily, but not entirely, after the assembly
process begins. Light-scattering and electron microscopic
studies with batroxobin have shown that normal fibers are
formed after removal of the A peptides only (Shen et al.,
1977; Hantgan and Hermans, 1979; Hantgan et al., 1983).
In other words, the cleavage of the B peptides is not
required for lateral aggregation of the protofibrils. On the
other hand, when the B peptide itself is removed, there is
trimerization but no fiber formation at physiological tem-
perature (Shainoff and Dardik, 1983). However, if this
reaction is carried out at lower temperatures (e.g., -200C
or lower), the protein does clot (Shainoff and Dardik,
1979). Aggregation resulting from removal of the B fibri-
nopeptides is abolished by removal of B# 1-42 by plasmin,
suggesting that the NH2-terminal portion of the (3-chain of
fibrin constitutes an important part of the "B" binding
site.
In this paper, I describe investigations into the mecha-
nism of assembly of the fibrin clot and provide new
information on how variations in the basic structural plan
can lead to clots with different physical properties. In
particular, structural studies have confirmed and extended
the above findings on the role of the removal of the
fibrinopeptides in the formation of fibrin. The band pat-
terns of fibrin formed with the various proteolytic enzymes
described above under different environmental conditions
were examined by electron microscopy and interpreted in
terms of molecular structure and packing. Furthermore,
the widths of the fibers made under all of these conditions
have been measured. The results indicate that the fiber
diameters are relatively uniform, but that the extent of
lateral aggregation of the fibers themselves varies.
MATERIALS AND METHODS
Fibrin Formation
Highly purified, plasminogen-free, human fibrinogen, 97-100% clottable,
was obtained from Imco Co., Stockholm, Sweden. The fibrinogen, at a
concentration of 0.5-2.0 mg/ml, was dialyzed into the appropriate buffer,
as described below; the standard fibrinogen buffer was 0.15 M NaCl, 0.05
M Tris-HCl, pH 7.4. Salt concentrations were varied from zero to 0.6 M;
pH from 5.0 to 9.5; temperature from 0 to 370C. Some of the most
commonly used conditions were 0.05 M NaCl, 0.05 M Tris-HCI, pH 7.4,
0°C; 0.15 M NaCl, 0.05 M Tris-HCl, pH 7.4, 0°C; 0.15 M NaCl, 0.05 M
Tris-HCI, pH 7.4, 20°C; 0.15 M NaCl, 0.05 M Tris-HCI, pH 7.4, 37°C;
0.40 M NaCl, 0.05 M morpholinoethane sulfonic acid, pH 6.0, 0°C; 0.40
M NaCl, 0.05 M Tris-HCI, pH 7.4, 0°C; 0.40 M NaCl, 0.05 M Tris-HCl,
pH 8.5, 0°C. Clotting was initiated by the addition of thrombin to a final
concentration of about 2 NIH U/ml. Alternatively, batroxobin (Ameri-
can Diagnostica, Inc., Greenwich, CT; or Pentapharm, Inc., Basel,
Switzerland) or venzyme (a generous gift of Dr. John Shainoff, Cleveland
Clinic or purchased from Diagnostica Stago, Inc., Paris, France) were
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used to selectively cleave either the A or B fibrinopeptides, respectively. A
radioimmunoassay system (Mallinkrodt Co., St. Louis, MO) was used for
detection of cleavage of fibrinopeptide A. In addition, cleavage of the A or
B fibrinopeptides was also followed by sodium dodecyl sulfate gel
electrophoresis of reduced samples (Wangh et al., 1983). Gel electropho-
resis of dissolved clots showed that there was no ligation by Factor XIII.
Under the conditions of the experiments described in this paper, both the
A and B fibrinopeptides were removed by thrombin; batroxobin cleaved
only the A peptide. Venzyme removed nearly all of the B fibrinopeptide
and <5% of the A peptide. Concentrations of enzyme were adjusted so
that clotting times were generally <10 min.
Electron Microscopy and Computer
Image Processing
Fibrin fibers were applied to 300 or 400 mesh carbon-coated Formvar
grids, either by touching a grid to a pre-formed clot, by clotting a thin film
of protein on a grid, or by applying a drop of dispersed fibers to the grid.
The aim of all of these preparative methods is to obtain a thin enough film
on the grid that the electron beam can penetrate for visualization of the
structure, while maintaining the integrity of the clot. They succeed to a
variable extent. Since all of these methods have their own difficulties, the
details of preparation are significant but have previously been fully
described elsewhere (Weisel, J. W., manuscript submitted for publica-
tion). The most reliable method for visualization of substructure was to
add thrombin to fibrinogen in a test tube, and then to disperse the clot
with a pasteur pipette just as it began to gel. However, because of concern
that the fiber diameters could change after the gelation point, samples
were also prepared from gels that had been allowed to stand for at least
100 times the clotting time so that they were fully formed, as well as by
producing clots directly on the grids. There were no differences in either
the appearances or the diameters of samples prepared in these different
ways. The fibers were then negatively contrasted with 1% uranyl acetate
and examined in a Philips 400 electron microscope outfitted with a low
dose kit. The microscope magnifications were calibrated with tropomyo-
sin paracrystals, with a repeat of 39.5 nm (Caspar et al., 1969). The
diameters of the fibers were measured from the electron micrographs with
an optical comparator. At least several hundred fibers were measured for
each set of conditions.
Electron microscope images of negatively contrasted fibrin were simu-
lated by computer modeling programs that have been described previ-
ously (Weisel et al., 1981; Cohen et al., 1983; Weisel et al., 1985).
Simulations were carried out on a Digital Equipment Corp. VAX 1/750
computer and the results displayed on an Advanced Electronics Design
767 color graphics terminal. The model for the shape of the fibrin
molecule was that previously determined from analysis of the x-ray
crystallographic data and electron microscope images (Weisel et al.,
1985). A wide variety of molecular packing schemes was examined.
RESULTS
Electron Microscopy of Fibers Formed
upon Removal of the A
Fibrinopeptides Only
Negatively contrasted human fibrin, formed by clotting
fibrinogen with thrombin under physiological conditions
(yielding [a, ,B, 'Y)]2), displayed a characteristic band pat-
tern in the electron microscope (Fig. 2 b). Similar struc-
tural studies were carried out on fibers produced by
clotting human fibrinogen with batroxobin, which removes
only the A fibrinopeptides (yielding [a, B/3, -Y]2). Fig. 2 c
shows a micrograph of such a fiber, formed at pH 7.4, 0.15
M NaCl, 370C. Except for normal variations in staining
and specimen preservation, which occur among all groups
of fibers, there is no detectable difference between fibers
produced with thrombin or batroxobin. It is also apparent
that the diameters of both of these particular fibers are
similar, but a quantitative determination of the average
fiber diameters will be described later in this paper.
Electron Microscopy of Fibers Formed
upon Preferential Removal of the
B Fibrinopeptides
The experiment corresponding to that just described, but
with venzyme (yielding [Aa, A, 7]2), cannot be carried out
because no clot is formed at 370C (see introduction).
However, the protein does polymerize at lower tempera-
tures. Hundreds of clots produced by adding venzyme to
human fibrinogen at OOC were examined in the electron
microscope. Such clots are somewhat different in gross
visual appearance from those made by cleavage with
thrombin or batroxobin; they have been described as
"gelatinous" (Shainoff and Dardik, 1983). Electron
microscopy revealed that such clots consist almost entirely
of fibers similar to those prepared by using thrombin. This
uniformity is important since a small percentage of A
fibrinopeptides are also cleaved with venzyme (Shainoff
and Dardik, 1983); if only a few normal fibers were
observed, they could be dismissed as due to this artifact.
Furthermore, the same results were obtained by re-precipi-
tating pure (Aa, f3, 7)2 prepared as described by Shainoff
and Dardik (1983). In this case, all of the fibers present
must be made up of molecules missing the B fibrinopep-
tides only. A representative example of one of the fibers
made by clotting human fibrinogen with venzyme is shown
in Fig. 2 a. Most of the fibers displayed striations with a
regular repeat of 22.5 nm. The band pattern of negatively
stained fibers is similar to that described above. The fibers
are generally not quite as well ordered as those produced
by thrombin or batroxobin, but all of the same features are
present. There is a broad light, stain-excluding band and
three narrower light bands, with the central one being
somewhat less distinct in appearance. Again, the fibers
appeared to be about the same width as those produced by
thrombin, but this question will be considered in more
detail below.
Computer Image Simulation of the Fibrin
Band Pattern
A molecular packing arrangement for fibrin fibers that
accounts for the electron microscope images and is consis-
tent with the chemical and physiological data has been
described (Weisel et al., 1981, 1983, 1985a). To interpret
the images obtained from electron microscopy of fibrino-
gen clotted by venzyme, it is important to determine if this
molecular packing scheme is the only one that can account
for the images. For this reason, the same computer
programs that have been used in the past to simulate
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FIGURE 2 Electron micrographs of negatively contrasted fibrin fibers produced by clotting human fibrinogen with several enzymes and
under various ionic conditions. Many other conditions were also examined; these are only a few representative images. All fibers were
negatively contrasted with 1% uranyl acetate. The repeat is 22.5 nm, and the band patterns are similar, but there are slight differences as
described in the text. The enzymes and ionic conditions for each image were as follows: (a) venzyme, 0.15 M NaCI, pH 7.4, 0°C; (b) thrombin,
0.15 M NaCI, pH 7.4, 370C; (c) batroxobin, 0.15 M NaCI, pH 7.4, 37°C; (d) thrombin, 0.05 M NaCI, pH 7.4, O°C; and (e) thrombin, 0.40 M
NaCI, pH 7.4, 0°C. Bar, 0.1 ,um.
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electron microscope images of the various crystal forms
were used to simulate the paracrystalline fibrin band
pattern. The constraints on this modeling were minimal:
the shape of the molecule was that determined previously
and the molecules were oriented roughly along the fiber
axis. As both the number of molecules and their locations
in space were varied systematically, the resulting band
patterns were observed on the monitor of a graphics
terminal. A great number and variety of possible molecular
packing schemes were attempted. This search could be
(c)
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exhaustive, since the pattern being simulated is only one-
dimensional. By this means, it was determined that it is
highly unlikely that any other packing model can account
for the striations of negatively contrasted fibrin. The
results of these experiments are not illustrated, since the
only successful simulations were those that have been
published previously (Weisel et al., 1981, 1983, 1985a). It
appears that the only way to obtain the observed band
pattern with a repeat of 22.5 nm is for the molecules to be
half staggered. In other words, the previously described
FIGURE 3 Electron micrographs of fibrin produced at high ionic strength and high pH. Fibrinogen in 0.40 M NaCl, pH 8.5 at 0°C was
clotted by thrombin or batroxobin (as indicated). (a) Low magnification field showing many fibers produced by clotting with thrombin. The
fibers are normal in appearance, except for their smaller diameter. Bar, 1.0 Atm. (b and c) Fibers produced by thrombin, shown at higher
magnification than in a. The cross-striations are similar to those of the wider fibers shown in Fig. 2. The particular fibers shown here are above
the average diameter for these conditions because the band pattern is clearer; however, even the thinnest fibers show some beading, although
the striations may not show up as clearly as they do in these images. (d) Fiber formed by cleavage of the A fibrinopeptides of fibrinogen by
batroxobin. This fiber is similar in appearance to those above. The band pattern is identical to those of the fibers above and in Fig.2. (b-d) Bar,
0.1 ,um.
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molecular packing uniquely accounts for the images of
fibrin fibers.
Fiber Diameter as a Function of pH, Ionic
Strength, and Temperature
The initial experiments described above suggested, unex-
pectedly, that there are not large differences among the
diameters of fibers formed after cleavage of fibrinogen
with the three enzymes, thrombin, batroxobin, and ven-
zyme. However, since there is a wide variation in fiber
widths in any one experiment, any quantitative conclusions
must be made on the basis of accurate measurement of a
statistically significant number of fibers. To investigate
further the factors influencing lateral aggregation, I also
measured the diameters of fibers prepared under a variety
of conditions of pH, ionic strength and temperature.
Except for the variables just listed, all other conditions
were kept constant. Fibers were negatively contrasted with
uranyl acetate and examined in the electron microscope.
At least several hundred fibers were measured for each
condition. A few representative examples of electron
micrographs of these fibers formed under different condi-
tions are shown in Fig. 2; an attempt was made to illustrate
the effect of variation of all of the parameters in this figure.
Fibers produced by cleavage with thrombin, batroxobin, or
venzyme and under ionic conditions of 0.05, 0.15, or 0.40
M NaCl and pH 6.0, 7.4, or 8.5 and 00, 200, or 370C were
extensively examined, although many other conditions
were also tested. The band pattern is the same in all cases.
Under most of the conditions of the experiments
described here, there was no readily apparent variation in
fiber diameter. An exception is the fibrin formed by either
batroxobin, venzyme, or thrombin at pH 8.5, 0.4 M NaCl.
These are the conditions for formation of fine clots. In this
buffer, nearly all of the fibers are considerably smaller in
diameter, agreeing with the results of Ferry and co-
workers using other techniques (most recently, see Muller
et al., 1984). Fig. 3 a is a field of fibers prepared at high
salt concentration and high pH as they appear at low
magnification in the electron microscope. Fig. 3,b-d are
micrographs of individual fibers clotted with thrombin or
batroxobin and shown at the same magnification as those
in Fig. 2. Although the fibers are smaller in diameter, their
band pattern is identical to that of the thicker fibers.
A summary of the results of this extensive series of
measurements of fiber diameters under many conditions is
shown in Fig. 4. Each column represents the average of
several hundred fibers; they are shaded differently to
distinguish fibers formed by the three proteolytic enzymes,
thrombin, batroxobin, and venzyme. It should be noted
that several columns are missing because des-BB fibrin
does not clot at higher temperatures. At the top of each
column is a line indicating one standard deviation. The
standard deviations are 15% of the measured fiber
widths, confirming the visual impression of a fairly large
variation of widths. Strikingly, the average fiber widths are
* thrombin (FPA & B)
13 batroxobin (FPA)
0 venzyme (FPB)E
c 60
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FIGURE 4 Chart of average diameters of fibers produced with different
enzymes and under different environmental conditions. Each particular
set of conditions is indicated at the bottom of the chart. At least several
hundred fibers were measured from electron micrographs of fibers
prepared under each set of conditions. Lines indicating one standard
deviation from the mean are shown for each column.
the same, within the variation of one standard deviation,
under all conditions and enzymes, except at pH 8.5 and 0.4
M NaCl. Under most conditions, then, the fibers are 85 +
13 nm in diameter.
Lateral Aggregation of Fibrin Fibers
During the course of the measurements of fiber diameter,
it soon became apparent that, under certain conditions,
there is substantial aggregation of fibers (Fig. 5). In other
words, fully formed fibers often appear to aggregate
side-by-side with one another. In carrying out the experi-
ments just described, measures were taken to minimize the
bias that aggregation could introduce. Most aggregated
fibers can be recognized since they usually do not associate
along their entire length (Fig. 6 a). Thus, it is important to
measure only fibers that can be observed along a substan-
tial portion of their lengths; then, diameters can be mea-
sured in places where they are not aggregated. This one
precaution eliminated nearly all aggregated fibers from
consideration. Occasionally, fibers were observed that
appeared to be single but showed a slight lateral disconti-
nuity somewhere along their length (Fig. 6 b). A few fibers
were eliminated on this basis.
Electron microscopy of fibrin at relatively low magnifi-
cations revealed a great variation in the extent of lateral
aggregation of the fibers. In all of the images, fibers
merged at certain points along their course and diverged
again to form a three-dimensional network. Under some
ionic conditions, there were only those few points of
contact, and the fibers were primarily separated from one
another. For example, there was little lateral aggregation
of fibers in 0.15 M NaCl upon cleavage with batroxobin
(Fig. 5 a) or in 0.40 M NaCl on cleavage with thrombin
(Fig. 5 c). On the other hand, under other conditions, such
as batroxobin cleavage in 0.05 M NaCl (Fig. 5 b) or
thrombin in 0.15 M NaCl (Fig. 5 d), thick bundles of
fibers associated side-by-side were observed. Depending
upon the ionic conditions and the fibrinopeptides cleaved, a
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FIGURE 5 Electron micrographs of separated and aggregated fibers. Under certain clotting conditions the fibers are primarily separated, as
in the micrographs on the left, while under other conditions many fibers aggregate laterally to form thicker bundles, as in the images on the
right. It should be noted, however, that conclusions should not be drawn from a single image. The results shown here are typical, but a variety
of images are observed for any one experiment. Also, note that the apparent diameters of individual fibers seen on first inspection of some
images at low magnification can be misleading (see text and Fig. 6). Furthermore, although the results described for some conditions are
clearly different from others, quantitative estimation of the extent of aggregation of the fibers has not been attempted. Clots here were
produced under the following conditions: All four were clotted at pH 7.4 and at 0OC; (a) batroxobin, 0.15 M NaCl; (b) batroxobin, 0.05 M
NaCl; (c) thrombin, 0.4 M NaCl; (d) thrombin, 0.15 M NaCI. Bar, 1.0 ,um.
variety of states in between were also seen. In general,
there is more lateral aggregation of fibers upon cleavage of
both sets of fibrinopeptides and as the ionic strength or pH
is decreased.
DISCUSSION
Intermolecular Binding Sites Exposed by
Removal of the B Fibrinopeptides and
Their Complementary Sites
In this section, I will first describe the relationship between
the known biochemical data on the binding sites and
structural studies on fibrin, and then show how the results
described in this paper may be interpreted to provide new
information on the localization and function of the B
fibrinopeptides and related complementary binding sites.
Any meaningful interpretation of the structural studies
presented above is dependent upon an adequate under-
standing of the molecular packing in the fibrin fiber. With
the recent development of a more accurate model for the
structure of fibrinogen (Weisel et al., 1981, 1985a; Cohen
et al., 1983), the band pattern of negatively contrasted
fibrin has now been analyzed and interpreted in some
detail (Weisel et al., 1983; Weisel, J. W., manuscript
submitted for publication). The results of these studies,
together with biochemical data from other laboratories,
indicate that the fibrin band pattern can be accounted for
simply and directly from the molecular structure and
packing, as follows. Fibrin monomers interact with each
other via complementary binding sites in the central and
distal end domains to form a protofibril made up of
molecules that are half-staggered and bonded end-to-end.
The broad, bright band arises from the juxtaposition of the
two distal end domains (-y domains) with the central
domain (disulfide knot), perhaps with some contribution
from the a domain. The narrower light bands on either side
come from the proximal end domains (fi domain). The
central light band that is somewhat variable in appearance
arises from the smallest, plasmin-sensitive domain that
interrupts the coiled-coil rod. As described above, the
analysis of almost every conceivable variation of molecular
packing has demonstrated that this interpretation is
unique.
The binding sites exposed by removal of the A fibrino-
peptides, called the "A" sites, are located in the central
domain, while the complementary sites, called the "a"
sites, are located in the y domain (Fig. 1). Analysis of the
orthogonal sheet microcrystal form, which is closely
related to fibrin, has revealed aspects of the structure of the
two-stranded protofibril (Weisel et al., 1983). The orthog-
onal sheet is made up of layers of tilted two-stranded
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FIGURE 6 Electron micrographs of the lateral aggregation of the fibrin fibers. These micrographs are shown at higher magnification than
those in Fig. 5, so that the nature of the lateral aggregation of the fibers can be seen in more detail. In many cases, the fibers line up so that the
striations of adjacent fibers are in register. (a) In this image there is still space between the upper and middle fiber, although their striations
are aligned. (b) Here several fibers have completely fused, but boundaries between them can occasionally be seen. Fibers that appear to be
considerably thicker than normal often have this appearance (e.g., Fig. 5, b and d). If such fibers are traced, it can be seen that most of them
are not be completely fused along their entire lengths. Bar. 0.1 IAm.
irotofibrils. As suggested by Fowler et al. (1981), all
riolecules in one filament of the protofibril face in the same
irection and the two filaments making up the protofibril
ace each other. The protofibril is a "closed structure" in
he sense that all binding sites (two "A" sites in the central
omain and one "a" in each distal end domain) interact
iith molecules in the adjacent, half-staggered filament.
The "B" sites exposed by removal of the B fibrinopep-
ides are also located in the central domain, since they are
t or near the amino terminus of the ,B-chain (Shainoff and
)ardik, 1979). On the other hand, the "b" sites have not
'reviously been localized. With the arrangement of proto-
ibrils predicted from the molecular packing in the orthog-
nal sheet (Weisel et al., 1983) and confirmed by the
imulations of the fibrin band pattern described above, the
b" sites would have to be in the distal end domain (or y
.omain) to interact with the central domain of the adjacent
alf-staggered molecule. The f domain, or proximal end
omain, is too far away to interact with the adjacent
entral domain (Fig. 1 and Weisel et al., 1985a), as it could
F the molecules were staggered by one third rather than
ialf the molecular length. This localization is strongly
uggested by the structural studies in this paper, but must
e confirmed by isolation of the binding peptides or other
iochemical experiments.
Interactions of the two sets of binding sites cannot be
identical, but they may be either very different, as depicted
in Fig. 1, or similar. First, consider the simplest interpreta-
tion of the data. By this scheme, if there were separate
binding sites for protofibril formation and lateral aggrega-
tion, exposed by cleavage of the A and B fibrinopeptides,
respectively, then there would be no protofibril formation
or lateral aggregation without exposure of the appropriate
sites. It has been demonstrated experimentally, however,
that normal fibers are formed upon removal of either
fibrinopeptide. Upon cleavage of the B fibrinopeptides
alone, at temperatures below - 1 50C, fibrin fibers are
formed that appear to be identical to those produced with
removal of either both fibrinopeptides or the A fibrinopep-
tides alone. Although these various fibers result from
cleavage with different enzymes, all of the details of the
staining patterns are the same. From the analysis of
computer simulations described above, we know that there
is a unique interpretation of this staining pattern in terms
of molecular structure and packing. The observation of
similar images thus indicates directly that the molecular
arrangement in these fibers is similar. The molecules must
be half staggered and bonded end-to-end. Hence, it is likely
that these fibers are also made up of two-stranded protofi-
brils. The intermolecular interactions would then be simi-
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lar, but mediated through the B:b sites rather than the A:a
sites. These results suggest a mechanism like that shown in
Fig. 7, where both sets of sites are involved in the formation
of protofibrils, which then aggregate with each other.
According to this scheme, the A:a and B:b binding sites on
one molecule interact with the same other molecule,
whereas in the mechanism depicted in Fig. 1, the interac-
tions occur with two separate molecules in a directional
manner.
Although there is clearly no necessity to remove both
fibrinopeptides to get lateral aggregation, there is still a
way in which there could be two opposite types of connec-
tivity of molecules associated with the two sets of binding
sites, as illustrated in Fig. 1. There could be two very
different kinds of protofibrils (as shown at the bottom of
Fig. 1): one as in the top two rows of filaments resulting
from cleavage of the A fibrinopeptides and the other
represented by the middle two rows formed by removal of
the B peptides. In this case, assume that once either type of
protofibril has been formed by cleavage of one pair of
fibrinopeptides, that protofibril could aggregate with oth-
ers without removal of the second set of fibrinopeptides.
Bonding would then be strengthened by cleavage of the
other fibrinopeptides. This hypothesis is not, however,
consistent with the data of Shainoff and Dardik (1983), in
which all initial aggregates formed by removal of different
fibrinopeptides have the same width but in which binding
is stronger with release of both fibrinopeptides. In other
words, taken as a whole, the experimental data supports
the mechanism shown in Fig. 7 rather than that in Fig. 1.
This overall conclusion agrees with that of Shainoff and
~~QC ab
Dardik (1983), based on physical chemical measurements,
that each of the sets of binding sites are capable of
functioning individually as aggregation sites.
The fibers produced after cleavage of the B fibrinopep-
tides are similar, then, to the other fibrin fibers, except for
the fact that they do not form at physiological tempera-
tures. In fact, even formation of insoluble polymers of
des-AA fibrin (or [a, Bo, Y]2) is eliminated at higher
temperatures (410C). Such a temperature dependence of
polymerization is common in biological reactions (cf.
Oosawa and Asakura, 1978). Temperature effects in the
polymerization of actin and tubulin, for example, have
been extensively studied. The nature and even the direction
of the temperature effects can be very different in diverse
systems. Both tubulin and actin polymers are more stable
at higher temperatures and tend to depolymerize at low
temperature; this is a common situation for reactions
involving hydrophobic bonding, which is endothermic and
increases in strength as the temperature increases. on the
other hand, the polymerization of (Aa, fi, y)2, or des-BB
fibrin, like that of flagellin, occurs only at lower tempera-
tures, and these structures depolymerize at higher temper-
atures. The direction of this temperature dependence sug-
gests that these reactions involve either hydrogen or ionic
bonding, or both, since the forces involved here increase
with decreasing temperature.
Lateral Aggregation of Protofibrils
to Form a Fiber
Fibrin fibers are formed by lateral aggregation of protofi-
brils. Since fibers result from removal of either set of
BAB . yt.
/
FIGURE 7 A model for fibrin assembly involving two sets of complementary binding sites: both for protofibril formation. The molecular
shape and all of the symbols are the same as in Fig. 1. In this case, however, both sets of binding sites, A:a and B:b, on any one molecule
interact with complementary sites on the same other molecule. In other words, the same aggregate is formed by the action of either batroxobin,
which removes only the A fibrinopeptides, or venzyme, which cleaves only the B peptides. Large protofibrils and fibers are produced by
venzyme only at low temperatures. The cleavage of both fibrinopeptides by thrombin results in the formation of the same, but more stable,
protofibril. The evidence of both structural data presented here combined with biochemical data described elsewhere (Shainoff and Dardik,
1983; see also the discussion in the text) indicates that this scheme is more likely than that in Fig. 1.
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fibrinopeptides, without the necessity of cleaving both sets,
this enzymatic step must be related only to protofibril
formation. The protofibrils themselves must then aggre-
gate by a self-assembly process, i.e., all of the information
necessary for the assembly of protofibrils to make a fiber is
present in the protofibril. There is no switch, like the
removal of the fibrinopeptides is for protofibril formation,
to initiate this reaction.
There may, however, be specific binding sites involved,
like those required for the formation of the protofibril
itself. The high degree of order in the axial direction in
fibrin could indeed suggest such specificity. If there are
specific binding sites, they must be weak enough so that
they are not ordinarily reactive between fibrinogen, or even
individual fibrin, molecules. There is an alternative possi-
bility to account for the lateral aggregation of protofibrils
that avoids the difficulties of sites that could cause interac-
tion of fibrinogen molecules. There could be a binding site
formed by the juxtaposition of the distal end domains of
two molecules bonded end-to-end that reacts with a com-
plementary binding site that is always present in the
central domain of an adjacent molecule. Both of these sites
would be on the face of the molecule opposite from the A:a
and B:b sites. The data of Olexa and Budzynski (1981) and
Budzynski et al. (1983) could be interpreted to suggest that
such binding sites may exist. These investigators found
that fragment E (the central region of the molecule) binds
to insolubilized, cross-linked fibrin or to D dimer (D is the
end region of the molecule; D dimer is two of these, bonded
end-to-end as they are in fibrin), but not to fibrinogen or
fibrin monomer or fragment D alone. These experiments
suggest that a new binding site is formed by the end-to-end
bonding of two molecules. Such a scheme would account
for the highly specific lateral aggregation of protofibrils
without the involvement of the B:b sites and without having
to postulate sites that are present on fibrinogen and could
cause its aggregation.
To assess accurately the extent of lateral aggregation of
protofibrils under various salt conditons, the diameters of
several hundred fibers were measured for each set of
conditions. The unexpected result of these measurements is
that, except at the extremes of high salt and high pH where
fine clots are produced, the diameters are remarkably
constant under a wide variety of conditions. The average
fiber diameter was found to be 85 ± 13 nm. With an
average protofibril spacing of -5 nm (Weisel, J. W.,
manuscript submitted for publication), there would be
about 14 to 22 protofibrils across a typical fiber. There
have been few other studies of fiber diameter by electron
microscopy. An early paper by Hawn and Porter (1947)
gives some measurements of fibers but does not address the
issues of heterogeneity and lateral aggregation of fibers.
Shah et al. (1982) measured fiber diameters under only
one set of conditions, but, interestingly, they found fibers at
both of the same diameters observed in the present study
under different ionic conditions. Muller et al. (1984) did
some measurements of clots under two conditions, but their
specimens were fixed, embedded, and sectioned or critical
point dried; consequently, although visualization of the
three-dimensional structure is better, they could not have
easily distinguished a thick fiber from several laterally
aggregated fibers.
Since salt concentration, pH, and temperature would be
expected to have some effect on the aggregation of protofi-
brils, there must be some sort of mechanism for maintain-
ing a constant diameter. Although the mechanism is
unknown at present, it is apparently not very rigorous or
precise since the range of sizes has a fairly large standard
deviation from the average size. At greater extremes of pH
and salt concentration, such as pH 8.5 and 0.4 M NaCl,
whatever forces are involved in width determination are
overcome, and thinner fibers are formed. The average fiber
diameter here was found to be -30-40 nm. This value is
slightly different from that measured by Muller et al.
(1984) under similar ionic conditions. Considering that
these authors used bovine fibrinogen rather than human
and that both their methods of clot formation and prepara-
tion for electron microscopy are considerably different
than those employed in the present study, I think that the
agreement of data is good. It should be noted of the
different methods employed that each has its own
strengths and weaknesses and was chosen for its applicabil-
ity to particular aspects of these two very different stud-
ies.
Lateral Aggregation of Fibers
As mentioned in the introduction, there has been a great
deal of research on the physical properties of clots formed
under various conditions. The striking differences between
coarse and fine clots are clearly obvious, even by eye, for
example. This is why the results indicating that the fibers
do not vary greatly in diameter were so unexpected. Fibrin
formation has also been an important focus for light-
scattering studies for many years (recent work includes
Burchard and Muller, 1980, 1982; Carr et al., 1977; Carr
and Hermans, 1978; Cavazza et al., 1981; Hantgan and
Hermans, 1979; Hantgan et al., 1980; Muller et al., 1981).
Results from many of these experiments from several
laboratories suggested that the fiber width varied widely.
The apparent discrepancies between results using these
two different techniques have been resolved in this paper.
Electron microscopy shows that, although the diameters
are relatively constant, the extent of aggregation of fibers is
not. This effect is graded, i.e., it appears to vary smoothly
with solvent conditions. Because of this effect, the extent of
aggregation of fibers is not easy to quantitate; quantitation
is better left to the method of light scattering since it
measures average or global properties, while electron
microscopy better displays the properties of individual
fibers. This is another example of the power of combining
these two methods, as discussed by Hantgan et al. (1980).
There are, however, dramatic differences in the appear-
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ance of the clot at opposite extremes of conditions. Fig. 5
shows electron micrographs of fields of fibers at low
magnification to indicate the differences in the extent of
aggregation of fibers. There is relatively little aggregation
of fibers produced by treatment of fibrinogen in 0.15 M
NaCl with batroxobin (Fig. 5 a) or in 0.4 M NaCl with
thrombin (Fig. 5 c). On the other hand, there is consider-
able aggregation upon cleavage with batroxobin in 0.05 M
(Fig. 5 b) or thrombin in 0.15 M NaCl (Fig. 5 d); under
these conditions, thick fiber bundles are often observed.
The pH and temperature were the same (pH 7.4 and 0°C)
for all of the experiments shown. It is important to note
that at physiological ionic strength (0.15 M NaCl) there
appears to be a considerable difference in the extent of
aggregation of fibers depending upon whether or not the B
fibrinopeptides have been released.
In contrast to previous research cited above, preliminary
results from a recent light-scattering study (Carr et al.,
1985) indicates that, in the presence of 5 mM CaCl2, there
is little difference in light-scattering parameters of clots
formed with thrombin and those formed with batroxobin.
Fibers made under these conditions must be analyzed by
electron microscopy to interpret these new light-scattering
results further. These results suggest, however, that other
factors, such as calcium, also play a role in the lateral
aggregation of fibrin fibers.
Little is yet known about the process of aggregation of
fibers but, it is interesting to note the appearance of
aggregated fibers at higher magnification in the electron
microscope. Fig. 6 a shows several fibers that appear to be
just beginning to coalesce. It may be seen that the struc-
tures quite often line up with the striations in all of the
fibers in register. Fibers that appear to be very broad are
occasionally seen (Fig. 6 b). That such structures represent
not a single thick fiber but several that have fused can
usually be shown by following the structures until they
divide. Even when this cannot be done, slight lateral
discontinuities across the width of the fiber, representing
planes of fusion, can usually be seen (Fig. 6 b).
Why Does Fibrinogen Have Two Pairs
of Fibrinopeptides?
A key question concerns the function of the B fibrinopep-
tides and the B:b binding sites. Part of the answer has
already come from previous biochemical studies, as dis-
cussed above. It is important to note that the present
structural studies are consistent with most light-scattering
and other chemical and physical data. We now know,
however, that all of these results must be interpreted in
terms of lateral aggregation of fibers rather than simply
fiber width. Removal of both sets of fibrinopeptides
appears to result in more lateral aggregation of fibers than
if only one is cleaved. There is a striking difference in
appearance in the electron microscope that parallels the
difference seen by light scattering. Like the changes in
light scattering, this effect is most apparent under physio-
logical conditions.
The cleavage of the B fibrinopeptides has been described
as having an effect similar to lowering the ionic strength
(Shen et al., 1977). These authors showed that, although
the removal of the B fibrinopeptides does not expose sites
unique for lateral aggregation, this event has profound
effects on the overall form of the clot and the kinetics of
clotting. There is a strong correlation between the kinetics
of fiber formation and lateral aggregation. If the clotting
reaction is fast, i.e., the gelation time is short, there is more
lateral aggregation of fibers than if clotting is slower.
Factors that cause the reaction to be faster, such as lower
ionic strength or pH, or removal of the B fibrinopeptides,
also tend to create more lateral aggregation. In other
words, the observed lateral aggregation of fibers to form
fiber bundles may be brought about by the normal process
of cleavage of the B fibrinopeptides or by the nonphysiolog-
ical change of ionic strength, pH, etc.
The energetics of the early stages of polymerization of
fibrin with different sets of fibrinopeptides missing has
been studied by Shainoff and Dardik (1983), using the
techniques of analytical ultracentrifugation and column
chromatography. They measured the relative strengths of
binding of the B:b and A:a binding sites, as well as the
effect of temperature on these reactions (see also Edgar
and Prentice, 1980). The results of these studies suggest
that there is strong cooperativity between the binding at
the two sites. These experiments also indicate that an
increased lateral aggregation of fibers may be an indirect
effect of strengthening the bonding in the protofibril. Thus,
a change in aggregation properties can be brought about
by many factors that affect the bonding between molecules
in the protofibril, such as ionic conditions, protein concen-
trations, or cleavage of the second set of fibrinopeptides.
Both strengthening of the bonding in the protofibril and
lateral aggregation increase the stability of the clot, which
has important clinical implications. For example, in vivo
administration of thrombin results in intravascular coagu-
lation, while administration of batroxobin results in defi-
brination. There is controversy over the mechanism of the
defibrination: whether the batroxobin creates finely dis-
persed microclots or only soluble fibrin, either of which
would be more easily lysed than a clot formed with
thrombin. Furthermore, batroxobin does not activate Fac-
tor XIII, which stabilizes fibrin with covalent cross-links.
In any case, a clot produced by thrombin is clearly more
stable with respect to plasmin cleavage than one formed by
batroxobin. Similarly, the necessity of cleavage of the B
fibrinopeptides for stabilization of the clot could act as a
preventative of intravascular coagulation by small amounts
of thrombin that disperse from the site of tissue injury
(Shen et al., 1977). Low concentrations of thrombin would
result in the removal of only the A fibrinopeptides so that
the clot would be readily dissolved. Alternatively, Shainoff
and Dardik ( 1983) suggest that the function of the delayed
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release of the B fibrinopeptides may be to allow the rapid
dissociation of early soluble fibrin complexes so that they
can equilibrate across interstitial fluids and to allow for
their rapid uptake by phagocytic cells.
Molecular Mechanism of Clot Assembly
We can now identify several distinct steps as part of the
molecular mechanism of formation of the fibrin clot (Fig.
8). The "switch" initiating the dramatic change in solubil-
ity of the molecule is the cleavage of the fibrinopeptides by
thrombin. Under normal physiological conditions, the A
peptides are cleaved first. The B fibrinopeptides are
cleaved more slowly, but it is not necessary for polymeriza-
tion to occur before they are removed (Nossel et al., 1983).
The fibrin molecules interact via the A:a complementary
binding sites discussed above to yield the two-stranded
protofibril; the cleavage of the B fibrinopeptides and
consequent interaction of the B:b sites strengthens the
fibrinogen
2-stranded protofibril
c=Qc=
fiber
111111111111HI lliii 1111 11111iiili 111111111lii 1111I
aggregation of fibers
1_i ii11 11li ii11 11IIli
liili 1111 ii11 ii11 ii11 1111
I1111 111111 1111 1111 1111 11111liii1lii 1111 111111liili
FIGURE 8 A depiction of several steps in the formation of a fibrin clot. Fibrinogen molecules are freely soluble in the blood. Upon cleavage of
one or both of the fibrinopeptides by thrombin, the molecules aggregate to form a two-stranded protofibril, made up of molecules that are half
staggered and bonded end-to-end. Protofibrils then aggregate laterally to form fibers. Fiber widths vary somewhat, but generally are similar
under a wide variety of conditions. Finally, the fibers themselves aggregate laterally to form thicker fibers. They tend to associate in register, as
shown here, but the extent of aggregation is highly dependent on the ionic and enzymatic conditions, as described in the text. Clearly, this
scheme is oversimplified. It leaves out several steps studied by other investigators, including details of the formation of oligomers, branching of
fibers to form a gel, and the creation of an ordered three-dimensional network. However, it is meant only to convey some of the major points of
this paper.
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protofibril. Protofibrils then aggregate laterally to form
fibers -85 nm in diameter. The fibers themselves also
aggregate laterally, often in such a way that adjacent
fibers are in register. The extent of aggregation of fibers
depends upon both the solvent conditions and whether or
not the B fibrinopeptides have also been cleaved. Fibers
must also branch so that a three-dimensional gel is formed
(Muller et al., 1984). Recently, there is evidence from gel
permeation experiments and scanning electron microscopy
that the fibrin gel itself is not a random network of fibers,
but is somewhat ordered (Blomback et al. 1984).
The new results presented here are consistent with what
has been observed for other biological assembly processes.
For the most part, biological structures are assembled in a
series of discrete steps. Thus, in this case, fibers of a certain
size are formed from protofibrils, and larger fibers are not
assembled de novo, but are made up of several smaller
fibers. Such a process permits simple steps with many
points of control. Furthermore, fibers with a limited width
are a very efficient way to fill space with a gel or plug using
only a small amount of material. The physical and
mechanical properties of the clot, which influence its
physiological and pathological properties, depend upon the
extent of lateral aggregation of fibers, which is determined
by ionic and enzymatic conditions.
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